LDL Cholesterol and Cardiovascular Events in a Population Network: One More Twist of an Endless Story.

High plasma levels of low-density lipoprotein cholesterol (LDL-C) have long been known to associate with a measurable increase of cardiovascular (CV) events in the general population. LDL-C lowering drugs, from the venerable statins to ezetimibe and PCSK9 inhibitors, are therefore pillars of the